Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-046978
Filing Date
2011-08-15
Accepted
2011-08-15 16:05:26
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-17995_110q.htm 10-Q 1587912
2 EX-31.1 a11-17995_1ex31d1.htm EX-31.1 9942
3 EX-31.2 a11-17995_1ex31d2.htm EX-31.2 9708
4 EX-32.1 a11-17995_1ex32d1.htm EX-32.1 5543
5 EX-32.2 a11-17995_1ex32d2.htm EX-32.2 5475
  Complete submission text file 0001104659-11-046978.txt   5307959

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clsp-20110630.xml EX-101.INS 678294
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsp-20110630.xsd EX-101.SCH 27567
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clsp-20110630_cal.xml EX-101.CAL 90695
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clsp-20110630_def.xml EX-101.DEF 139053
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT clsp-20110630_lab.xml EX-101.LAB 409498
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsp-20110630_pre.xml EX-101.PRE 177737
Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170 2126729190
CALLISTO PHARMACEUTICALS INC (Filer) CIK: 0001142380 (see all company filings)

EIN.: 651107840 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32325 | Film No.: 111036261
SIC: 2834 Pharmaceutical Preparations